|
Located in one of the world's leading
medical device research and development regions, Biosensors-USA
was established in 1990 as a subsidiary of Biosensors International Group,
headquartered in Bermuda, and as the U.S. exponent of
the Biosensors International Group.
Biosensors-USA functions as the R&D
center for Biosensors International Group. The highly
dedicated researchers of Biosensors-USA design state-of-the
art products for cardiovascular markets. With active
collaborations with leading universities and hospitals
in the USA, Biosensors products are designed to achieve
medical excellence by incorporating both state-of-the-art
technology and practical solutions for the requirements
of demanding markets.
The advanced development programs of
the U.S. R&D team span pharmaceuticals, coating
technologies and polymer engineering.
These efforts are supported by the R&D group in Singapore,
which fields its own team of world-class technology innovators
and has direct contact with Asian's leading physicians.
The U.S. facility supports North American
and South American medical device sales, distributing
cardiac interventional and general medical products throughout
the Western Hemisphere, and procuring raw materials.
Biosensors has also established a network of distributors
and direct sales offices to sell and support sales of
our products in markets worldwide. Some of our key customers
include Fukuda Denshi, GE Medical Systems and DeRoyal,
among many others.
For additional information, please contact
us at:
BIOSENSORS
INTERNATIONAL USA
20280 Acacia Street, Suite 300,
Newport Beach, CA 92660, U.S.A.
Tel: (949) 553-8300
Fax: (949) 553-9129
Email: sales@biosensors-usa.com |
|